期刊文献+

PARG基因沉默抑制小鼠结肠癌CT26细胞系体外淋巴管形成 被引量:5

PARG silencing inhibits lymphangiogenesis in mouse colonal carcinoma in vitro
下载PDF
导出
摘要 目的初步探讨聚腺苷二磷酸核糖水解酶(PARG)基因沉默对肿瘤淋巴管形成的影响。方法 CT26细胞分为未转染组,空载组和PARG-shRNA慢病毒载体转染组,经嘌呤霉素筛选后获得稳定转染细胞克隆。用Westernblot法检测PARG、PARP-1、NF-κB和VEGF-C蛋白表达。给BALB/c小鼠腹腔注射不完全弗氏佐剂,诱导良性淋巴管瘤形成,分离并培养小鼠淋巴管内皮细胞(LEC)。免疫荧光细胞化学检测VEGFR-3和Podoplanin的表达,共培养实验检测LEC体外淋巴管样结构的形成。结果与对照组相比,PARG-shRNA慢病毒载体转染CT26细胞系后PARP-1、NF-κB及VEGF-C蛋白表达显著减弱,相对灰度值分别为1.0±0.05,0.9±0.02和0.2±0.02(P<0.05)。LEC表达VEGF-C和Podoplanin;PARG沉默组的LEC体外形成淋巴管样结构明显较未转染组和空载组少(P<0.05)。结论 PARG抑制肿瘤淋巴管形成可能与降低VEGF-C的表达有关。 Objective To investigate the influence of PARG silencing on the tumor lymphangiogenesis.MethodsLentiviral-PARG-shRNA was transfected into mouse colon carcinoma CT26 cell line.The CT26 cells expressing PARG gene were established by puromycin selection.The expressions of PARG,PARP-1,NF-κB and VEGF-C protein were detected by Western blot analysis.BALB/c mice benign lymphangiomas in abdominal cavity were induced by injection of 0.2 mL incomplete Freund's adjuvant(IFA,1∶ 1 with PBS) and mechanically disrupted to obtain LECs.Expressions of VEGFR-3 and Podoplanin were analyzed by immunofluorescence cytochemistry.The capability of LECs to form lymphatic vessel-like structures was evaluated by a LEC-CT26 cells co-culture method.Results The expression levels of PARP-1,NF-κB,and VEGF-C were reduced in PARG-silencing CT26 cells(P0.05).Benign lyphangiomas were successfully induced by emulsified IFA.The expressions of VEGFR-3 and Podoplanin were positive in isolated LECs.The lymphatic vessel-like structures in PARG-silencing CT26 cells were significantly less than that in the control group(P 0.05).Conclusion PARG silencing significantly reduces VEGF-C expression and suppresses the formation of lymphatic vessel-like structures.So PARG silencing may havean antilymphangiogentic effect and therefore prevent the metastatic dissemination through lymph system.
出处 《基础医学与临床》 CSCD 北大核心 2011年第6期625-629,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(30870946)
  • 相关文献

参考文献3

二级参考文献16

  • 1郝兰香,王娅兰,李圆圆.大肠癌PARP表达与P-selectin和ICAM-1表达的相关性[J].基础医学与临床,2006,26(8):882-887. 被引量:17
  • 2郝兰香,王娅兰,蔡莉,李园园.5-AIQ对大肠癌细胞系HT-29细胞PARP活性抑制的生物学作用[J].癌症,2007,26(6):566-571. 被引量:6
  • 3Cuzzocrea S, Mazzon E, Di Paola R, et al. 5-Aminoisoquinolinone reduces colon injury by experimental colitis [ J ]. Naunyn Schmiedebergs Arch Pharmacol, 2004,370 ( 6 ) : 464 - 473.
  • 4Cuzzocrea S, McDonald MC, Mazzon E, et al. Effects of 5- aminoisoquinolione, a water-soluble, potent inhititor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury [ J ]. Biochem Pharmacol, 2002,63 (2) : 293 - 304.
  • 5Salim K, Fenton T, Bacha J, et al. Oligomerization of Gprotein-coupled Receptors Shown by Selective Co-immunoprecipitation [ J]. JBC, 2002, 277 (18) : 15482 - 15485.
  • 6Martin-Oliva D, O' Valle F, Munoz-Gamez JA, et al. Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia [ J]. Oncogene, 2004, 23 (31 ) : 5275 - 5283.
  • 7Paul OH, Christine B, Cornelia L, et al. Transcriptional coactivation of nuclear factor-KB-dependent gene expression by p300 Is regulated by Poly (ADP)-ribose polymerase-1 [J]. J Biol Chem,2003,278(46) :45145 -45153.
  • 8Chandak PG, Gaikwad AB, Tikoo K. Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP[ J]. Phytotherapy Research, 2009, 23 ( 1 ) :72 - 77.
  • 9Cuzzocrea S, Mazzon E, Genovese T, et al. Role of poly (ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice [ J ]. Free Radic Biol Med, 2007, 42(1) :90 -105.
  • 10Veres B, Radnai B, Gallyas F, et al. Regulation of kinase cascades and transcription factors by a Poly(ADP-Ribose) polymerase-1 inhibitor, 4-Hydroxyquinazoline, in lipopolysaccharide-Induced inflammation in mice [ J]. JPET, 2004, 310(1) :247 -255.

共引文献19

同被引文献20

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部